YAP-dependent necrosis occurs in early stages of Alzheimer's disease and regulates mouse model pathology

被引:70
|
作者
Tanaka, Hikari [1 ,2 ]
Homma, Hidenori [1 ,2 ]
Fujita, Kyota [1 ,2 ]
Kondo, Kanoh [1 ,2 ]
Yamada, Shingo [3 ]
Jin, Xiaocen [1 ,2 ]
Waragai, Masaaki [4 ]
Ohtomo, Gaku [5 ]
Iwata, Atsushi [5 ]
Tagawa, Kazuhiko [1 ,2 ]
Atsuta, Naoki [6 ]
Katsuno, Masahisa [6 ]
Tomita, Naoki
Furukawa, Katsutoshi
Saito, Yuko [7 ,8 ]
Saito, Takashi [9 ]
Ichise, Ayaka [10 ]
Shibata, Shinsuke [10 ]
Arai, Hiroyuki [7 ]
Saido, Takaomi [9 ]
Sudol, Marius [11 ]
Muramatsu, Shin-ichi [12 ]
Okano, Hideyuki [10 ]
Mufson, Elliott J. [13 ]
Sobue, Gen [6 ]
Murayama, Shigeo [14 ]
Okazawa, Hitoshi [1 ,2 ]
机构
[1] Tokyo Med & Dent Univ, Med Res Inst, Dept Neuropathol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan
[2] Tokyo Med & Dent Univ, Ctr Brain Integrat Res, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan
[3] Shino Test Corp, Minami Ku, 2-29-14 Ohino Dai, Sagamihara, Kanagawa 2520331, Japan
[4] Higashi Matsudo Municipal Hosp, Dept Neurol, Matsudo, Chiba 2702222, Japan
[5] Univ Tokyo, Grad Sch Med, Dept Neurol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan
[6] Nagoya Univ Grad Sch Med, Dept Neurol, Brain & Mind Res Ctr, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan
[7] Tohoku Univ, Inst Dev Aging & Canc, Div Brain Sci, Dept Geriatr & Gerontol,Aoba Ku, 4-1 Seiryo Cho, Sendai, Miyagi 9808575, Japan
[8] Natl Ctr Neurol & Psychiat, Natl Ctr Hosp, Dept Lab Med, 4-1-1 Ogawa Higahsi Machi, Kodaira, Tokyo, Japan
[9] RIKEN, Ctr Brain Sci, Lab Proteolyt Neurosci, 2-1 Hirosawa, Wako, Saitama 3510198, Japan
[10] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan
[11] Natl Univ Singapore, Yong Loo Li Sch Med, Dept Physiol, 2 Med Dr, Singapore 117597, Singapore
[12] Jichi Med Univ, Dept Neurol, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290496, Japan
[13] Barrow Neurol Inst, Dept Neurobiol & Neurol, 350 W Thomas Rd, Phoenix, AZ 85013 USA
[14] Tokyo Metropolitan Inst Gerontol, Dept Neuropathol Brain Bank Aging Res, Itabashi Ku, 35-2 Sakae Cho, Tokyo 1730015, Japan
关键词
YES-ASSOCIATED PROTEIN; BALLOONED NEURONS; CELL-DEATH; NEURODEGENERATIVE DISEASES; CORTICOBASAL DEGENERATION; AMYLOID-BETA; ACTIVATION; PHOSPHORYLATION; APOPTOSIS; PATHWAY;
D O I
10.1038/s41467-020-14353-6
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The timing and characteristics of neuronal death in Alzheimer's disease (AD) remain largely unknown. Here we examine AD mouse models with an original marker, myristoylated alanine-rich C-kinase substrate phosphorylated at serine 46 (pSer46-MARCKS), and reveal an increase of neuronal necrosis during pre-symptomatic phase and a subsequent decrease during symptomatic phase. Postmortem brains of mild cognitive impairment (MCI) rather than symptomatic AD patients reveal a remarkable increase of necrosis. In vivo imaging reveals instability of endoplasmic reticulum (ER) in mouse AD models and genome-edited human AD iPS cell-derived neurons. The level of nuclear Yes-associated protein (YAP) is remarkably decreased in such neurons under AD pathology due to the sequestration into cytoplasmic amyloid beta (A beta) aggregates, supporting the feature of YAP-dependent necrosis. Suppression of early-stage neuronal death by AAV-YAPdeltaC reduces the later-stage extracellular A beta burden and cognitive impairment, suggesting that preclinical/prodromal YAP-dependent neuronal necrosis represents a target for AD therapeutics.
引用
收藏
页数:22
相关论文
共 50 条
  • [21] Reduction of β-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease
    Daniel Paris
    Nowell J Ganey
    Vincent Laporte
    Nikunj S Patel
    David Beaulieu-Abdelahad
    Corbin Bachmeier
    Amelia March
    Ghania Ait-Ghezala
    Michael J Mullan
    Journal of Neuroinflammation, 7
  • [22] Reduction of β-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease
    Paris, Daniel
    Ganey, Nowell J.
    Laporte, Vincent
    Patel, Nikunj S.
    Beaulieu-Abdelahad, David
    Bachmeier, Corbin
    March, Amelia
    Ait-Ghezala, Ghania
    Mullan, Michael J.
    JOURNAL OF NEUROINFLAMMATION, 2010, 7
  • [23] Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease
    Lim, GP
    Yang, F
    Chu, T
    Chen, P
    Beech, W
    Teter, B
    Tran, T
    Ubeda, O
    Ashe, KH
    Frautschy, SA
    Cole, GM
    JOURNAL OF NEUROSCIENCE, 2000, 20 (15): : 5709 - 5714
  • [24] Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer's disease
    Sun, Xiao-ying
    Li, Ling-jie
    Dong, Quan-Xiu
    Zhu, Jie
    Huang, Ya-ru
    Hou, Sheng-jie
    Yu, Xiao-lin
    Liu, Rui-tian
    JOURNAL OF NEUROINFLAMMATION, 2021, 18 (01)
  • [25] Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer’s disease
    Xiao-ying Sun
    Ling-jie Li
    Quan-Xiu Dong
    Jie Zhu
    Ya-ru Huang
    Sheng-jie Hou
    Xiao-lin Yu
    Rui-tian Liu
    Journal of Neuroinflammation, 18
  • [26] Liraglutide ameliorates insulin receptor pathology in a mouse model of Alzheimer's disease
    Manning, S. B.
    Coakley, M. F.
    McClean, P. L.
    Hoelscher, C.
    O' Neill, C.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2011, 180 : S482 - S482
  • [27] Ligand for Translocator Protein Reverses Pathology in a Mouse Model of Alzheimer's Disease
    Barron, Anna M.
    Garcia-Segura, Luis M.
    Caruso, Donatella
    Jayaraman, Anusha
    Lee, Joo-Won
    Melcangi, Roberto C.
    Pike, Christian J.
    JOURNAL OF NEUROSCIENCE, 2013, 33 (20): : 8891 - 8897
  • [28] Axonal pathology in mouse models of Alzheimer's disease
    Stokin, GB
    NEUROBIOLOGY OF AGING, 2004, 25 : S17 - S17
  • [29] Preventing Alzheimer's Pathology in a Preclinical Mouse Model
    Shaw, Phyllis
    FASEB JOURNAL, 2015, 29
  • [30] Neuroinflammation in early stages of Alzheimer's disease and Parkinson's disease
    Eikelenboom, Piet
    Crosswell, A.
    van Engen, C.
    Limper, M.
    Hoozemans, J. J. M.
    Veerhuis, R.
    van Gool, W. A.
    Rozemuller, J. M.
    ADVANCES IN ALZHEIMER'S AND PARKINSON'S DISEASE: INSIGHTS, PROGRESS, AND PERSPECTIVES, 2008, 57 : 113 - 121